Obesity Conferences | Obesity Conferences 2023 | Top Obesity Conferences | Obesity Meetings | International Obesity Conferences | PULSUS Conferences | CME Conferences | USA | Europe | Asia

About Obesity Conferences

Obesity is quickly becoming the most important health problem of the twenty-first century, according to several experts. It's a disorder that starts in childhood, grows throughout maturity, and causes a slew of health issues. Environmental and behavioural triggers, genetic and biological variables, and other exacerbating situations all play a role in its development and treatment. Diabetes mellitus type 2 (DM2) is a metabolic disorder caused by faults in insulin activity in the peripheral tissues. Damage to organs, including the eyes, kidneys, and heart, as well as nerves and arteries, occurs as a result of persistent hyperglycemia.

Obesity is described as an excess of adipose tissue in the body. Because adiposity is difficult to measure using traditional testing, body weight has been utilised as an indirect marker of the degree of adiposity. In the 1980s, the concept of body mass index (BMI) was invented, and cut points for overweight and obesity in adult men and women were established.

Even when there are no clinical problems, diabetes is today considered a vascular disease. This approach is clearly important in terms of treatment, but it is less certain in terms of diagnosis, leading to a disagreement with the European Society of Cardiology's clinical practise guidelines on diabetes and pre-diabetes, which strongly recommend that all patients with DM2 undergo tests to detect myocardial ischemia. Treatment for diabetes, multiple sclerosis, and obesity requires a change in lifestyle. If all of these disorders are caused by the expression of a certain genetic predisposition that is aggravated by an unhealthy lifestyle, then changing that lifestyle is the first step in treatment. Diet, exercise, and behaviour are the three main components of any such change. Whether or not DM2 is present, weight loss is linked to significant decreases in CVD risk. The ultimate goal is to achieve a BMI of 25 (a more realistic value would be 27) or a waist circumference of less than the MS criteria's threshold. Some medicines can help with weight loss in addition to diet and exercise. Only sibutramin and orlistat have been approved for use thus far, despite the fact that both have poor results and are only moderately well tolerated.

We are pleased to announce that our Committee members holding the Obesity Conference, which will provide a meaningful framework for meaningful interactions, engagement, and connection.

The Obesity Congress will provide insights from the world's leading experts on the latest trends, new innovative preventive and treatment strategies, and cutting-edge research findings on all aspects of obesity and weight management.

This conference is a global forum for Obesity Professionals, and we guarantee that you will learn about the most recent methods for obesity cure and therapy from researchers from all over the world. The relationship between health and wealth, the impact of social media and stigmatisation, globalisation, and consumerism, as well as the root causes of obesity, will all be addressed at this global summit. The congress will teach you how to develop comprehensive, personalised treatment plans for patients suffering from complex adiposity-related diseases such as chronic kidney disease, postpartum weight management, weight recovery after surgery, and depression or mental health issues related to obesity.

The International Conference will be a two-day event with the goal of providing conference attendees with a once-in-a-lifetime opportunity to learn and make new connections through a high-quality scientific programme that includes keynote speeches, poster presentations, workshops, discussions, and networking events. This is your best chance to reach the most people in the obesity, weight management, and endocrinology communities, including researchers, scientists, surgeons, healthcare professionals, endocrinologists, nutritionists, fitness experts, pharmacists, clinicians, entrepreneurs, key players in industry, government representatives, policymakers, and people from all over the world interested in learning about obesity and its consequences.

We are raising awareness and increasing knowledge of the underlying causes of obesity, as well as the initiatives that must be implemented to address them, and we hope that you will join us in this effort.

Market Analysis:

According to a new report by Reports and Data, the global obesity treatment market is expected to reach USD 27.10 billion by 2028, at a CAGR of 16.7 percent. The rising prevalence of obesity as a result of sedentary lifestyles, unhealthy eating habits, and a lack of physical activity is one of the key parameters driving market revenue growth. Increased commercial availability of weight-management programmes, rising demand for technologically advanced weight-loss devices and equipment, and an increase in government initiatives to raise awareness about obesity and its negative health consequences all contribute to global market growth. Furthermore, rising health and fitness trends such as gym culture, rising cosmetic concerns, particularly among millennials, rising inclination toward weight-loss surgeries, and rising healthcare expenditure create market growth opportunities.

Obesity is a medical condition characterised by an increase in the size of fat cells in the body. Diabetes, cardiovascular disease, high blood pressure, and several types of cancer are all associated with this condition. Obesity is caused by a variety of factors, including a lack of sleep, physical inactivity, and an excessive consumption of junk food. Changes in lifestyle, such as proper diet and physical fitness, are thought to be the mainstay of obesity treatment. Dietary changes, increased physical activity, and behavioural changes have all been shown to help improve the condition and prevent obesity-related health problems. Physicians may prescribe specific weight-loss procedures and medications in more serious cases. Some well-known FDA-approved weight-loss medicines include orlistat (Xenical, Alli), naltrexone-bupropion (Contrave), phentermine-topiramate (Qsymia), semaglutide (Wegovy), and liraglutide (Saxenda).

Current Research trends:

· Obesity is no longer just a problem of wealthy countries; it now affects countries of all economic levels, bringing with it a wave of illness and lost productivity.

· Obesity has nearly doubled worldwide since 1980, with slightly more than 200 million adult men and slightly less than 300 million adult women obese.

· Obesity rates in children have also been steadily rising: 43 million preschool children were overweight or obese in 2010, a 60 percent increase since 1990.

· According to a 2014 study of overweight and obesity in children and adults from 1980 to 2013, the proportion of overweight or obese adults increased worldwide, and prevalence increased significantly in both developed and developing countries.

· These increases in child and adult obesity rates show no signs of abating in the absence of concerted efforts to combat the epidemic.

The United States has the highest rates of overweight and obesity of any high-income country, with nearly one-third of the population obese—a figure that is expected to rise to around 50% by 2030. Obesity, like most other health issues, has a disproportionate impact on different segments of society. Rates are higher among the poor than among those with higher incomes. Those with a lower level of education have higher rates than those with a higher level of education. Furthermore, certain minority groups, particularly African-American and Hispanic women, have significantly higher rates than other groups.

Metrics:

Pulsus Group is one of the world’s remarkable Scientific Conference Organizers who have their individuality on all the spectrums of Science, Technology and Business. A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to make an international gathering a great success; be it research or academic or industrial.

Research personnel, Dieticians, Physicians, Surgeons, Academicians, Research institutes, Industrialists and students are the key participants who show intense desire in attending the Pulsus conferences on Obesity as represented in the below quoted metrics. Conferences based on obesity, metabolic disorders, metabolic syndromes and other related field shows a significantly large number of unique visitors and page views which were proved to be a thriving success.

Pulsus further extends its frontier through maintaining its every conference proceeding in its respective conference webpages and its official social media accounts. Thus, aspiring to have the participation of the international scientific and industrial communities to come and experience the pack of talks, discussions, product exhibitions and alliances.